Hoffmann-LaRoche, Horizon Therapeutics, Galapagos, Syneos Health, Boehringer Ingelheim, Bellerophon Therapeutics, Fibrogen.
He has received industry-sponsored research support to his institution for anti-fibrotic treatment from F. Roman has served on a data safety and monitoring board for Novartis for anti-fibrotic treatment. Roman also serves as CEO of the Jane & Leonard Korman Respiratory Institute of Jefferson Health and National Jewish Health.Ģ022 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. He is currently with Jefferson Health in Philadelphia, Pa, where he serves as the Ludwig Kind Professor of Medicine enterprise division chief, Pulmonary, Allergy and Critical Care Medicine and director of the Pulmonary and Critical Care Medicine Fellowship Program. Roman has been a member of the ATS since 1988, and he is committed to diversity, equity and inclusion, having served as a founding leader of the Health Equity Subcommittee within the Health Equity and Diversity Committee. Jesse Roman, MD, originally elected in 2022, will serve as the ATS Treasurer through 2025.ĭr. She has participated in National Institutes of Health-supported research on sphingolipids and the effect of vaping on lung parenchyma. She served as a consultant for Ceramedix for antibody therapies. Petrache and colleagues as part of the University of Indiana Center for Biomedical Innovation and is funded by Biomotiv. She has conducted research supported by Allinaire, which evolved from work of Dr. Petrache is a scientific co-founder of Allinaire Therapeutics which develops novel therapeutics for pulmonary arterial hypertension (PAH) and other pulmonary diseases, including EMAP II.
She also serves as chief of Pulmonary, Critical Care and Sleep Medicine, associate vice president of Faculty Development, and Wollowick Chair in COPD Research & Professor of Medicine at National Jewish Health.Ģ022 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Petrache is professor of Medicine at the University of Colorado. Petrache will serve as President in 2024-2025.ĭr. Irina Petrache, MD, ATSF, elected in 2021, will serve as the Secretary.
0 kommentar(er)
